A pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.
Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
Pharmacists working with long-term care centers benefit from streamlined billing to support and build patient trust.
New research highlights abemaciclib and ribociclib as promising treatments for early HR-positive, HER2-negative breast cancer, emphasizing survival benefits and adverse effects.
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
Artificial intelligence (AI) is transforming drug development by automating routine tasks, enhancing clinical trials, and expediting drug discovery, ultimately leading to more personalized treatments.
Pharmacists’ pharmacotherapeutic expertise helps them advocate for their patients and assist providers.
Pharmacy managers must not only possess high levels of emotional intelligence, but should also encourage development among staff that facilitates more effective and creative outlets for frustration.
Results from the INCREASE study shed light on the value of the pharmacist in medication therapy management.
The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
The 2025 SPPCP Virtual Conference on Tuesday, May 20, 2025, will offer pharmacists and clinicians a full day of CE-accredited sessions on complex pain management, opioid use disorder, mentorship, and innovative approaches in palliative care, with opportunities for networking and professional development.
Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.
Taking a few seconds to double-check a prescription can have significant impacts on patient safety
Pharmacists can play a key role in providing education and guidance to patients with glaucoma.
The expanded role of oncology pharmacists includes the opportunity to work in ambulatory settings, infusion centers, delivery of specialized in pharmacy services, evaluation of investigational new drugs, and manager roles in drug chain supply and in coordination of care.
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
Practical strategies for pharmacy professionals to build a social media presence, expand their network, and advance their careers in the evolving digital landscape.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
Because decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Beth A. Malow, MD, MS, FAAN, said that pharmacists and health care professionals are at the frontlines of collaborating and raising awareness of climate change’s impacts.
Specialty distributors provide strategic partnerships that enhance pharmaceutical manufacturers' ability to bring innovative medicines to market.
RSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.
Panelists discuss how future research in refractory metastatic colorectal cancer must prioritize patient-centered approaches by incorporating patient advocates to understand what patients truly value and care about most, citing the example of rectal cancer where clinicians focus on recurrence risk while patients prioritize ostomy concerns, emphasizing that historically clinical trial design has not adequately asked patients about their priorities, and explaining that staying current with rapidly evolving data requires multidisciplinary strategies including journal clubs with board-certified oncology pharmacists, morning huddle meetings for clinical pearls, pharmacy resident presentations, professional organization memberships like ASCO for daily updates, and increasingly using social media platforms like Twitter as starting points to identify relevant clinical developments before delving deeper into primary literature.
Challenges remain, however, to therapy development for a limited patient population.
How patients acquire NSCLC plays a role in health outcomes, with never-smoker patients having genetically different disease than the same disease in smokers.